2022 - Research.com Best Female Scientist Award
2015 - Member of the National Academy of Medicine (NAM)
Beth Y. Karlan mostly deals with Ovarian cancer, Internal medicine, Cancer research, Cancer and Oncology. Ovarian cancer is a subfield of Genetics that she studies. Her Internal medicine research includes themes of Gastroenterology and Endocrinology.
Her studies in Cancer research integrate themes in fields like Mutation, Germline mutation, DNA methylation, microRNA and Tumor suppressor gene. Beth Y. Karlan has researched DNA methylation in several fields, including Ovarian carcinoma and Methylation. As part of one scientific family, Beth Y. Karlan deals mainly with the area of Oncology, narrowing it down to issues related to the Colorectal cancer, and often Genetic testing.
Her primary scientific interests are in Ovarian cancer, Internal medicine, Oncology, Cancer research and Cancer. Her research on Ovarian cancer focuses in particular on Ovarian carcinoma. Her Internal medicine study frequently links to adjacent areas such as Endocrinology.
In her study, which falls under the umbrella issue of Oncology, Case-control study is strongly linked to Odds ratio. Her Cancer research research includes elements of DNA methylation, Cancer cell, Carcinogenesis, Gene and Metastasis. Her Gynecology research incorporates elements of Family history and Obstetrics.
Beth Y. Karlan mainly investigates Internal medicine, Oncology, Ovarian cancer, Breast cancer and Cancer. Her study looks at the relationship between Internal medicine and fields such as Genetic correlation, as well as how they intersect with chemical problems. Her work deals with themes such as Precision medicine, Epidemiology, Serous fluid, Single-nucleotide polymorphism and Endometrial cancer, which intersect with Oncology.
Her Serous fluid research integrates issues from Ovarian carcinoma, Transcriptome, Ovarian tumor, Biomarker and Histology. Her studies deal with areas such as Cancer research, Genome-wide association study, Disease and Germline as well as Ovarian cancer. The Breast cancer study combines topics in areas such as Published Erratum, Mutation and Bioinformatics.
Beth Y. Karlan mainly focuses on Oncology, Internal medicine, Ovarian cancer, Serous fluid and Cancer. Beth Y. Karlan interconnects Genome-wide association study, Germline, Hazard ratio, Stage and Breast cancer in the investigation of issues within Oncology. The study of Internal medicine is intertwined with the study of Cancer syndrome in a number of ways.
Beth Y. Karlan has included themes like Epidemiology, Cell type, Disease and Mesenchymal stem cell, Cell biology in her Ovarian cancer study. The study incorporates disciplines such as PAX8, Ovarian carcinoma, Transcriptome, Fallopian tube and Ovarian tumor in addition to Serous fluid. Her Cancer study combines topics in areas such as Oophorectomy and Adverse effect.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Integrated genomic analyses of ovarian carcinoma
D. Bell;A. Berchuck;M. Birrer;J. Chien.
Integrated genomic characterization of endometrial carcinoma
Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers
Wataru Sakai;Elizabeth M. Swisher;Beth Y. Karlan;Mukesh K. Agarwal.
Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer
David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria.
Nature Reviews Cancer (2015)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Ovarian Cancer: Screening, Treatment, and Follow-up
Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld.
Periostin secreted by epithelial ovarian carcinoma is a ligand for αVβ3 and αVβ5 integrins and promotes cell motility
Lindsay Gillan;Daniela Matei;David A. Fishman;C. S. Gerbin.
Cancer Research (2002)
Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation
Amy Finch;Mario Beiner;Jan Lubinski;Henry T. Lynch.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: